View : 251 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김경효*
dc.date.accessioned2026-04-09T16:31:10Z-
dc.date.available2026-04-09T16:31:10Z-
dc.date.issued2026*
dc.identifier.issn0095-1137*
dc.identifier.otherOAK-39191*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/275127-
dc.description.abstractStreptococcus pneumoniae (pneumococcus) is a leading cause of community-acquired pneumonia and invasive diseases, particularly among children and the elderly. The introduction of pneumococcal conjugate vaccines has significantly reduced invasive pneumococcal disease, but the prevalence of non-vaccine serotypes and newly emerging serotypes is increasing globally. Thus, accurate serotyping is essential for epidemiological surveillance and the development of next-generation multivalent pneumococcal vaccines. Conventional serotyping methods, including multiplex polymerase chain reaction (mPCR), monoclonal antibody (mAb) assays, and Quellung reaction using rabbit antisera, are limited by serotype coverage and cross-reactivity, making the detection of new or emerging serotypes challenging. In this study, we developed a nanopore Cas9-targeted serotyping (nCATSerotyping) platform, which employs Cas9-mediated enrichment of the capsular polysaccharide synthesis locus followed by Oxford Nanopore sequencing. Applying this method to 276 clinical pneumococcal isolates collected in South Korea (2018–2020), we achieved a serotyping success rate of 97.10% (268∕276), significantly outperforming conventional methods such as mAb and mPCR, which identified only 76.45% (211∕276) of isolates. Whole-genome sequencing of the remaining eight non-typeable isolates revealed them to be non-pneumococcal (oral streptococci), confirming 100% accuracy for S. pneumoniae serotyping. Importantly, our method identified emerging and underrepresented serotypes, including serotype 13 and null capsule clade strains. nCATSerotyping offers a rapid, accurate, and comprehensive solution for pneumococcal serotyping, with significant advantages in identifying novel and non-typeable strains. This scalable platform will be a valuable tool for global serotype surveillance and next-generation multivalent pneumococcal vaccine development. Copyright © 2025 Ji et al.*
dc.description.sponsorshipAmerican Society for Microbiology*
dc.languageEnglish*
dc.subjectCRISPR-Cas9*
dc.subjectemerging serotypes*
dc.subjectnanopore sequencing*
dc.subjectserotyping*
dc.subjectStreptococcus pneumoniae*
dc.subjectvaccine development*
dc.titleAccurate serotype identification of Streptococcus pneumoniae using nanopore Cas9-targeted serotype identification (nCATSerotyping)*
dc.typeArticle*
dc.relation.issue2*
dc.relation.volume64*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.journaltitleJournal of Clinical Microbiology*
dc.identifier.doi10.1128/jcm.00984-25*
dc.identifier.wosidWOS:001650953200001*
dc.identifier.scopusid2-s2.0-105029922906*
dc.author.googleJi H.J.*
dc.author.googleA-Yeung J.*
dc.author.googleHan S.H.*
dc.author.googleKim M.-K.*
dc.author.googleLamien C.E.*
dc.author.googleWijewardana V.*
dc.author.googleAhn K.B.*
dc.author.googleKim K.-H.*
dc.author.googleSong J.Y.*
dc.author.googleSeo H.S.*
dc.contributor.scopusid김경효(35448653000)*
dc.date.modifydate20260615164147*
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE